Dana-Farber Researchers Create Open-Access Predictive Tool to Enhance Smoldering Multiple Myeloma Monitoring
In a significant leap forward for the management of a perplexing blood cancer precursor, researchers at Dana-Farber Cancer Institute in ...
Tag: Dana-Farber Cancer Institute research
Dana-Farber Research Advances Lead to FDA Label Update for Primary CNS Lymphoma
In a groundbreaking advancement for the treatment of central nervous system (CNS) lymphoma, the U.S. Food and Drug Administration (FDA) ...
Antibody-Drug Conjugates Enhance Outcomes in Advanced Triple-Negative Breast Cancer Patients Unsuitable for Immune Checkpoint Inhibitors
In a groundbreaking advancement in the treatment of aggressive breast cancers, researchers have unveiled promising results from the ASCENT-03 trial, ...
Combination Chemotherapy Enhances Overall Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
In a groundbreaking advancement in the treatment of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
Dana-Farber Unveils Innovative Diagnostic Tool Transforming Acute Leukemia Detection
In a groundbreaking advancement poised to revolutionize acute leukemia diagnosis and treatment, researchers at the Dana-Farber Cancer Institute have unveiled ...
Study Reveals Impact of Diet on Survival Rates in Stage III Colon Cancer Patients
A groundbreaking new analysis from Dana-Farber Cancer Institute highlights a significant link between diet, physical activity, and survival outcomes in ...
EQUAL Study Initiates Lung Cancer Screening Trial Targeting High-Risk Individuals
A groundbreaking clinical study spearheaded by researchers at the Dana-Farber Cancer Institute in Boston is embarking on an innovative quest ...
Dana-Farber Nurses Showcase Groundbreaking Research at 2025 Oncology Nursing Society Congress
Nurses have always played a pivotal role in the healthcare system, especially in oncology, where they serve not just as ...
Revolutionary Genomic Screening Tool Facilitates Precision Reverse-Engineering of Cellular Genetic Programming
In an extraordinary advancement for the field of genetics, researchers associated with the Dana-Farber Cancer Institute have unveiled a groundbreaking ...
FDA Grants Approval for Innovative Dual-Action Therapy Targeting Previously Treated Advanced Neuroendocrine Tumors, Supported by Dana-Farber Research
Cabozantinib, an innovative oral tyrosine kinase inhibitor, has recently received approval from the U.S. Food and Drug Administration (FDA) for ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!